GlassScriptPhysician profile
John D Joseph
NPI 1205258340
$1,492.29
in general payments reported to CMS, 2019-2025
11 companies · $575 in 2025
The $575 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $101 · 2022: $142 · 2023: $393 · 2024: $282 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,249.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $701.63 | 2022-2025 | Rukobia, Dovato, Apretude |
| Merck Sharp & Dohme LLC | $220.14 | 2021-2025 | Pifeltro, Delstrigo, Capvaxive |
| Janssen Biotech, INC. | $188.93 | 2021-2023 | Symtuza |
| Exact Sciences Corporation | $88.98 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $78.25 | 2024-2025 | Freestyle Libre 3 |
| Pfizer INC. | $75.18 | 2021-2025 | |
| Glaxosmithkline, LLC. | $56.93 | 2023-2025 | Shingrix, Arexvy |
| Indivior INC. | $23.73 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.73 | 2022 | |
| Amgen INC. | $19.49 | 2024 | Repatha |
| Phadia US INC. | $18.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.